Intrinsic Edge Capital Management LLC Corcept Therapeutics Inc Transaction History
Intrinsic Edge Capital Management LLC
- $471 Million
- Q1 2025
A detailed history of Intrinsic Edge Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 122,557 shares of CORT stock, worth $8.86 Million. This represents 2.97% of its overall portfolio holdings.
Number of Shares
122,557
Previous 186,150
34.16%
Holding current value
$8.86 Million
Previous $9.38 Million
49.23%
% of portfolio
2.97%
Previous 1.38%
Shares
4 transactions
Others Institutions Holding CORT
# of Institutions
469Shares Held
83.4MCall Options Held
1.42MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.2 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$722 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$558 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$444 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$280 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.74B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...